Vyvanse and Taurine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Taurine (taurine). Common drug interactions include palpitations among females and drug intolerance among males.
The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Taurine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Taurine?
Taurine has active ingredients of taurine. eHealthMe is studying from 1,015 Taurine users. Check the latest studies of Taurine.
13 people who take Vyvanse and Taurine together, and have interactions are studied.

What are the common drug interactions of Vyvanse and Taurine, by gender? *:
female:
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Bedridden
- Crying
- Drug ineffective
- Drug withdrawal convulsions
- Fatigue (feeling of tiredness)
- Hepatic enzyme increased
- Influenza
- Memory impairment
male:
- Drug intolerance (drug sensitivity)
- Dyspnoea (difficult or laboured respiration)
- Hypertension (high blood pressure)
- Weight decreased
What are the common drug interactions of Vyvanse and Taurine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Drug withdrawal convulsions
30-39:
n/a
40-49:
- Essential tremor
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Road traffic accident
50-59:
- Pain
- Bedridden
- Influenza
- Mobility decreased (ability to move is reduced)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 69.23%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 46.15%
- Perennial Allergy (airborne allergy): 2 people, 15.38%
- Migraine (headache): 2 people, 15.38%
- Hypersensitivity: 2 people, 15.38%
- Food Allergy: 2 people, 15.38%
- Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and Taurine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vyvanse and Taurine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Taurine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Taurine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Taziki S, Sattari MR, Egbal MA, "Evaluation of amitriptyline-induced toxicity in freshly isolated rat hepatocytes and the protective role of taurine", Life Sci J, 2015 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Taziki S, Sattari MR, Egbal MA, "Evaluation of amitriptyline-induced toxicity in freshly isolated rat hepatocytes and the protective role of taurine", Life Sci J, 2015 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and taurine (the active ingredients of Vyvanse and Taurine, respectively), and Vyvanse and Taurine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fentanyl cause Stools - Watery? - 8 seconds ago
- Could Fentanyl cause Diarrhea? - 8 seconds ago
- Could Zestoretic cause Weakness? - 10 seconds ago
- Could Flonase cause Papilloma Viral Infection? - 15 seconds ago
- Could Accuretic cause Gastroesophageal Reflux Disease? - 23 seconds ago
- Hyperkalemia and Haemoglobin Abnormal - 26 seconds ago
- Could Patanase cause Appetite Decreased? - 29 seconds ago
- Could Patanase cause Appetite - Decreased? - 29 seconds ago
- Could Dexamethasone cause Hyperammonaemia? - 30 seconds ago
- Drug interactions of Aleve and Zocor - 35 seconds ago